Diadema Partners »

Contineum Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 120k 16.39

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
Henderson Group
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management

View all funds holding Contineum Therapeutics